From manufacturing to patient: Ensuring stability and integrity of frozen faecal microbiota capsules during storage and shipping in the setting of the FRESCO trial
Background: The ongoing FRESCO trial [ref:1] is designed to assess the efficacy and safety of long-term (12 weeks) oral administration of frozen encapsulated faecal microbiota (FM) and a sterile microbiota filtrate (FMF) compared to placebo (PL) in patients with mild to moderate active ulcerative [for full text, please go to the a.m. URL]
Institutions
- Helmholtz Centre for Infection Research (DE)
- Jena University Hospital (DE)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2025-11-11
- DOI
- https://doi.org/10.3205/25gaa22
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00